Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Diseases × Denosumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 22 Neoplasms 11 Prostatic Neoplasms 8 Multiple Myeloma 8 Neoplasm Metastasis 7 Giant Cell Tumor of Bone 7 Osteoporosis 4 Fractures, Bone 4 Kidney Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Non-Small-Cell Lung 3 Bone Diseases, Metabolic 3 Bone Diseases 3 Spinal Cord Compression 2 Smoldering Multiple Myeloma 2 Recurrence 2 Parathyroid Neoplasms 2 Melanoma 2 Lymphoma 2 Lung Neoplasms 2 Bone Neoplasms 2 Bone Cysts, Aneurysmal 2 With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer Metastatic 1 Paraproteinemias 1 Ovarian Neoplasms 1 Osteosarcoma 1

Interventions

palbociclib 6 Letrozole 6 Docetaxel 6 Anastrozole 6 exemestane 5 Trastuzumab 5 Fulvestrant 5 ribociclib 4 entinostat 4 abemaciclib 4 Cyclophosphamide 4 pyrotinib 3 Doxorubicin 3 Sodium Chloride 2 Paclitaxel 2 Lapatinib 2 Gonadotropin-Releasing Hormone 2 Exercise 2 Everolimus 2 Epirubicin 2 Capecitabine 2 Botulinum Toxins, Type A 2 AZD9833 2 tucatinib 1 sacubitril and valsartan sodium hydrate drug combination 1 pertuzumab 1 pembrolizumab 1 pegfilgrastim 1 ipatasertib 1 gadoterate meglumine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04711109 2025-04-02

BRCA-P

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting

Breast Diseases, Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡